We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aoxing Pharmaceutical Company New (delisted) | AMEX:AXN | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.1218 | 0.00 | 01:00:00 |
RNS Number:0844J Alexon Group PLC 24 March 2003 For Immediate Release 24 March, 2003 ALEXON GROUP PLC Preliminary Results for the 52 weeks ended 25 January, 2003 Alexon Group plc, the leading retailer of ladieswear, menswear and shoes, announces Preliminary Results for the 52 weeks ended 25 January, 2003. * Operating profit, before amortisation of goodwill, increased 25.2% to #30.3m (2002: #24.2m); * Turnover increased 6.6% to #398.3m (2002: #373.6m); * Like-for-like sales increased by 3.9%; * Alexon brands gained market share in a difficult market with operating profit of #21.0m (2002: #20.2m); * Dolcis performed strongly with operating profits of #2.0m (2002: loss #0.6m); * Bay Trading made further progress with operating profit of #4.1m (2002: #2.1m); * Menswear demonstrated continued growth with operating profit of #3.2m (2002: #2.5m); * Earnings per share, before amortisation of goodwill, increased 40.1% to 34.4p (2002: 24.6p); * Final dividend declared of 4.7p, making a total of 6.0p for the year (2002: 3.0p), up 100%; * Strong cash inflow provides Group with net cash of #8.3m (2002: net debt of #2.3m) John Osborn, Chief Executive, commented: "I am delighted to report another excellent year for Alexon. Despite the challenging economic climate, all divisions have performed well, demonstrating solid growth and contributing to group profitability. The business in its current form, now has a good spread of quality brands across three sectors of retailing (Ladieswear, Menswear and Shoes) and is well balanced between High Street Shops and Departmental Stores. Strong organic growth potential is underpinned by sound defensive characteristics." For further information: Alexon Group 020 7623 8000 (today) & 01582 723131 (thereafter) John Osborn, Chief Executive Robin Piggott, Finance Director Buchanan Communications 020 7466 5000 Richard Darby/Bobbie Swanson CHIEF EXECUTIVE'S REPORT Results Operating profit for the year before amortisation of goodwill was #30.3 million as against #24.2 million for the prior year, an increase of 25.2%. Group sales for the year increased on a like-for-like basis by 3.9% on gross margins level ith last year. Strong performances came from Dolcis, Bay Trading and Menswear, our 1999 acquisitions, which contributed significantly to the profits for the year. Despite the slowdown in pre-Christmas trading, stocks ended the year well under control and the strong cash inflow during the year left the Group with net cash of #8.3 million compared with net debt of #2.3 million at the end of the prior year. Alexon Brands Operating profit for the division was #21.0 million against #20.2 million last year, reflecting like-for-like sales growth of 1.3%, on slightly lower gross margins. This was a pleasing performance in a difficult market and reflected market share gains at the expense of our competitors. The strongest performing brands were Kaliko, which has gone from strength to strength, and Minuet, the petite brand, which continued its rapid expansion with a further 25 outlets opened during the year. The ongoing introduction of more contemporary elements into the ranges resulted in sound performances from Eastex and Alexon, the latter in particular benefiting from the growth in Alex & Co, its more fashionable sub-brand. Sales in Dash were flat, following a strong performance in the prior year. Ann Harvey had a disappointing year as a result of a weak product offer and a number of changes have now been made in the buying team. Current Trading Sales to date in the current year are in line with plan and we are continuing to gain market share. Dolcis Dolcis ended the year with an operating profit of #2.0 million, against an operating loss of #0.6 million in the previous year. This was an excellent performance reflecting a greatly improved product offer and the benefits from rationalisation of retail space. Like for like sales increased by 12.8% over the prior year, achieved on higher margins. The main thrust of growth came from ladies' shoes, accounting for 70% of the business, which benefited from more professional sourcing and the selection of product ranges with a broader age and fashion appeal. The shoe concessions in Bay Trading and Envy made good progress during the year. Current Trading Sales and margins have continued to be strong in the current year, with good reactions from customers to new season's merchandise. Bay Trading Bay Trading had another excellent year achieving an operating profit of #4.1 million for the year compared with #2.1 million last year. Like-for-like sales grew by 1.0%, on higher gross margins. The buying team have continued to inject more interest and variety into the fashion ranges, at the same time retaining the key value proposition. Profitability was further enhanced by the opening of 23 new outlets (including 19 concessions), the expansion of Bay Angel (the sub-brand geared to the 7 to 14 year old market), and the introduction of own brand accessories. Current Trading Performance in the current year has continued in the same vein as last year with sales and margins in line with plan. Menswear The operating profit for the division was #3.2 million, as against #2.5 million in the prior year. Whilst like-for-like sales increased by 7.2%, lower achieved margins reflected the need to clear stocks after slower than expected pre-Christmas trading, which particularly affected the menswear market. Envy continued its growth with 7 new openings bringing the total to 50 shops at the year end. Particularly pleasing has been the continued development of womenswear which is now on offer in 17 Envy shops and it is our intention that womenswear will be incorporated into all future shops. The year saw continued growth in casualwear concessions in department stores. This will help to offset the loss of contribution from Top Man suit concessions, the last of which closed in March 2003. Current Trading Sales in the current year are in line with plan, and the response to the new ranges is encouraging. The strength of the product offer, coupled with further outlet growth, should ensure the Division's continued progress. Outlook The business, in its current form, now has a good spread of quality brands across three sectors of retailing (Ladieswear, Menswear, and Shoes), and is well balanced between High Street Shops and Departmental Stores. Strong organic growth potential is underpinned by sound defensive characteristics. Dividend The Group again enjoyed strong cash flow during the year. In recognition of the increased importance of dividends in the current market, the Board are recommending a final dividend of 4.67p per ordinary share be paid on 30 June 2003 to shareholders on the register on 6 June 2003, making a total of 6p for the year, an increase of 100%. Outlets A breakdown of outlets as at 25 January 2003 is as follows:- UK UK European Shops Concessions Concessions Total Alexon Brands 85 770 82 937 Dolcis 69 104 - 173 Bay Trading 142 54 - 196 Style 50 88 - 138 Total 346 1,016 82 1,444 John Osborn 24 March 2003 Alexon Group plc Consolidated Profit and Loss Account For the 52 weeks to 25 January 2003 2003 2002 Note #000 #000 Turnover 1 398,346 373,632 Cost of sales (341,780) (324,125) Gross profit 56,566 49,507 Administrative expenses : before goodwill amortisation (10,211) (9,838) goodwill amortisation (2,400) (2,400) (12,611) (12,238) Distribution costs (16,007) (15,437) Operating profit before goodwill amortisation 30,348 24,232 Goodwill amortisation (2,400) (2,400) Operating profit 1 27,948 21,832 Net interest payable (240) (1,048) Profit on ordinary activities before tax 27,708 20,784 Tax on profit on ordinary activities (8,227) (6,661) Profit for the financial period 19,481 14,123 Ordinary dividend (3,546) (1,814) Non-equity preference dividend (1,267) (1,267) Transfer to reserves 14,668 11,042 Earnings per share 2 Basic 30.42p 20.72p Diluted 28.64p 20.23p Adjusted 34.43p 24.58p Alexon Group plc Consolidated balance sheet As at 25 January 2003 2003 2002 Note #000 #000 #000 #000 Fixed assets Intangible assets 39,574 41,974 Tangible assets 21,191 17,873 Investments 3,214 836 63,979 60,683 Current assets Stock 50,151 49,192 Debtors 28,624 23,508 Cash at bank and in hand 11,761 2,225 90,536 74,925 Creditors falling due within one year 3 (49,855) (44,821) Net current assets 40,681 30,104 Total assets less current liabilities 104,660 90,787 Creditors falling due after more than one year (80) (22) Provisions for liabilities and charges (3,605) (4,584) 100,975 86,181 Capital and reserves Called up share capital 8,190 8,234 Share premium account 31,093 30,907 Capital redemption reserve fund 481 381 Profit and loss account 61,211 46,659 Total shareholders' funds 100,975 86,181 Alexon Group plc Consolidated Statement of Cash Flows For the 52 weeks to 25 January 2003 2003 2002 Note #000 #000 #000 #000 Net cash flow from operating activities 4 31,711 26,892 Returns on investments and servicing of finance Interest received 267 41 Interest paid (310) (1,084) Interest element of finance lease payments (115) (219) Non- equity dividends paid (1,268) (1,267) (1,426) (2,529) Taxation Corporation tax paid (5,591) (4,154) Capital expenditure Purchase of tangible fixed assets (9,378) (4,356) Receipts from sales of tangible fixed assets 18 12 (9,360) (4,344) Equity dividends paid (1,991) (1,847) Net cash inflow before management of liquid resources and financing 13,343 14,018 Management of liquid resources Increase in short term deposits (10,000) - Financing Issue of ordinary share capital 242 37 Purchase of own shares (2,915) (2,994) Repayment of loan notes (1,016) (9,341) Capital element of finance lease payments (580) (1,120) (Decrease)/increase in cash in the period 5 (926) 600 Alexon Group plc Notes 1. Turnover and operating profit comprise : Turnover Operating profit 52 weeks to 52 weeks to 52 weeks to 52 weeks to 25 January 26 January 25 January 26 January 2003 2002 2003 2002 #000 #000 #000 #000 Alexon Brands 185,184 175,666 20,986 20,199 Bay Trading 86,582 80,083 4,090 2,081 Dolcis 67,223 62,167 2,022 (574) Style Menswear 59,357 55,716 3,250 2,526 398,346 373,632 30,348 24,232 Goodwill amortisation (2,400) (2,400) 27,948 21,832 2. The calculation of basic earnings per ordinary share is based on profits of #18,214,000 (2002 : #12,856,000) after deducting preference dividends, and on 59,875,174 ordinary shares (2002 : 62,054,976 ) being the weighted average number of ordinary shares in issue. The earnings figure for adjusted earnings per share excludes goodwill amortisation. In calculating diluted earnings per share the weighted average number of ordinary shares in issue is adjusted to assume conversion of the convertible preference shares and the exercise of all dilutory share options granted to directors and key employees. Reconciliations of the earnings and weighted average number of shares are set out below. Earnings (#) Weighted average Per share number of shares (pence) Adjusted earnings per share 20,614,000 59,875,174 34.43 Goodwill amortisation (2,400,000) - (4.01) Basic earnings per share 18,214,000 59,875,174 30.42 Effect of dilutive convertible securities : preference shares 1,263,000 6,658,468 (1.15) options - 1,473,829 (0.63) Diluted earnings per share 19,477,000 68,007,471 28.64 3. Creditors falling due within one year may be analysed as follows: 2003 2002 #000 #000 Bank loans and overdrafts 2,253 1,791 Obligations under finance leases and hire purchase contracts 399 1,037 Trade creditors 11,085 10,944 Other creditors 4,845 4,627 Taxation and social security costs 6,098 5,596 Corporation tax 6,525 3,248 Accruals and deferred income 15,188 14,655 Loan notes 687 1,703 Proposed dividend 2,775 1,220 49,855 44,821 4. Reconciliation of operating profit to net cash inflow from operating activities: 2003 2002 #000 #000 Operating profit 27,948 21,832 Depreciation 5,644 6,189 Amortisation of goodwill 2,400 2,400 Loss on disposal of fixed assets 398 322 Increase in stock (959) (1,243) (Increase)/decrease in debtors (4,475) 191 Increase/(decrease) in creditors 1,312 (1,448) Decrease in provisions (979) (1,351) Amortisation of investments 422 - Net cash inflow from operating activities 31,711 26,892 5. Analysis of change in net debt At At 26 January Cash flow Other non 25 January 2002 cash changes 2003 #000's #000's #000's #000's Cash 2,225 (464) - 1,761 Overdrafts (1,791) (462) - (2,253) (926) Loan notes : current (1,703) 1,016 - (687) Finance leases : current (1,037) 580 58 (399) non current (22) - (58) (80) Liquid resources - 10,000 - 10,000 Total (2,328) 10,670 - 8,342 2003 2002 6. Reconciliation of movement in cash to movement in net funds #000 #000 (Decrease)/increase in cash (926) 600 Repayment of finance leases 580 1,120 Repayment of loan notes 1,016 9,341 Increase in liquid resources 10,000 - Movement in the period 10,670 11,061 Net debt at beginning of period (2,328) (13,389) Closing net funds/(debt) 8,342 (2,328) 7. The financial statements do not constitute statutory accounts. The results for the 52 weeks ended 25 January 2003 are extracts from the group accounts for that period which will be delivered to the Registrar of Companies in due course and on which the auditors have given an unqualified opinion which does not contain a statement under Section 237 (2), (3), or (4) of the Companies Act 1985. 8. The results for the 52 weeks ended 26 January 2002 have been extracted from the statutory accounts for that period which have been delivered to the Registrar of Companies and on which the auditors gave an unqualified report which did not contain a statement under Section 237 (2), (3), or (4) of the Companies Act 1985. 9. The Company's AGM will be held on 18 June 2003. This information is provided by RNS The company news service from the London Stock Exchange END FR EAPDFALXDEFE
1 Year Aoxing Pharmaceutical Company New (delisted) Chart |
1 Month Aoxing Pharmaceutical Company New (delisted) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions